Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Kaplan

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of the American Psychoanalytic Association|January 1, 1981
From discovery to validation: a basic challenge to psychoanalysisA H Kaplan
AIDS Research and Human Retroviruses|June 10, 1997
Characterization of V3 loop of HIV type 1 spreading rapidly among injection drug users of Manipur, India: a molecular epidemiological perspectiveA H Kaplan
Psychiatric Journal of the University of Ottawa : Revue De Psychiatrie De L'Universite D'Ottawa|November 1, 1987
Obsessive compulsive phenomena in adult obsessionality, compulsive personality disorder and obsessive compulsive disorder (neurosis)A H Kaplan
Food and Drug Law Journal|January 1, 1995
Fifty years of drug amendments revisited: in easy-to-swallow capsule formA H Kaplan
AIDS Research and Human Retroviruses|July 1, 1996
Constraints on the sequence diversity of the protease of human immunodeficiency virus type 1: a guide for drug designA H Kaplan
Medical Instrumentation|July 1, 1974
Editorial: Some observations on pending device legislationA H Kaplan
Biomedica Biochimica Acta|January 1, 1991
The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicityA H Kaplan, R Swanstrom
The American Journal of Psychiatry|May 1, 1986
The dying psychotherapistA H Kaplan, D Rothman
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartmentsA H Kaplan, R Swanstrom
Journal of Virology|October 1, 1994
The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiencyA H Kaplan, M Manchester, R Swanstrom
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of the American Psychoanalytic Association|January 1, 1981
From discovery to validation: a basic challenge to psychoanalysisA H Kaplan
AIDS Research and Human Retroviruses|June 10, 1997
Characterization of V3 loop of HIV type 1 spreading rapidly among injection drug users of Manipur, India: a molecular epidemiological perspectiveA H Kaplan
Psychiatric Journal of the University of Ottawa : Revue De Psychiatrie De L'Universite D'Ottawa|November 1, 1987
Obsessive compulsive phenomena in adult obsessionality, compulsive personality disorder and obsessive compulsive disorder (neurosis)A H Kaplan
Food and Drug Law Journal|January 1, 1995
Fifty years of drug amendments revisited: in easy-to-swallow capsule formA H Kaplan
AIDS Research and Human Retroviruses|July 1, 1996
Constraints on the sequence diversity of the protease of human immunodeficiency virus type 1: a guide for drug designA H Kaplan
Medical Instrumentation|July 1, 1974
Editorial: Some observations on pending device legislationA H Kaplan
Biomedica Biochimica Acta|January 1, 1991
The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicityA H Kaplan, R Swanstrom
The American Journal of Psychiatry|May 1, 1986
The dying psychotherapistA H Kaplan, D Rothman
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartmentsA H Kaplan, R Swanstrom
Journal of Virology|October 1, 1994
The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiencyA H Kaplan, M Manchester, R Swanstrom
Pageof 4